drugset / Trial / NCT06409494
Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
RandomizedParallel-groupDouble-blindPrevention
Summary
Phase 1 clinical trial to evaluate the safety of HZV-1 and HZV-2 vaccines in healthy adults aged 50 to 69 years who have voluntarily given written consent to participate in this study.
Timeline
- Start
- 2024-07-15
- Primary completion
- 2025-07-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EuHZV | Vaccine | 0.5 ml | Intramuscular |
| Comparator | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | 0.5 ml | Intramuscular |